FUS and myxoid liposarcoma: Myxoid liposarcoma (MLPS) is characterized by pathognomonic chromosomal translocations t(12;16)(q13;p11), resulting in the FUS–DDIT3 fusion oncoprotein, which has been detected in more than 90% of MLPS [23], while in a smaller portion (reportedly around 3%) of cases, EWSR1–DDIT3 is fused as a result of the gene arrangement t(12;22)(q13;q12) [24].